A new clinical trial has found that fluvoxamine — commonly used to treat depression — seems to reduce the risk of hospitalization with COVID-19.
Cheap antidepressant could help treat COVID-19, study finds
© The Crystal Eyes
A new clinical trial has found that fluvoxamine — commonly used to treat depression — seems to reduce the risk of hospitalization with COVID-19.
© The Crystal Eyes